ArticleBMJ open2026

Dihydroartemisinin for the treatment of polycystic ovary syndrome: study protocol for a multi-centre placebo-controlled randomised clinical trial.

Liangshan Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.